Cancer.Net Associate Editor: Gynecologic Cancers
Stanford University School of Medicine, Stanford, CA
Dr. Jonathan S. Berek is the Laurie Kraus Lacob Professor at the Stanford University School of Medicine. Dr. Berek helped establish and is the Director of the Stanford Women’s Cancer Center, which is one of the first programs in the nation to combine breast and gynecologic oncology with a women’s genetics program and supportive services. He is the Director of the Stanford Health Care Communication Program, the Director of Communication Programs, Stanford Comprehensive Cancer Institute, for which he has directed a series of short documentary films and conducts educational programs in effective and compassionate medical communication. He also serves as the physician leader for the planning of the Stanford Cancer Hospital.
Dr. Berek served as Chair of the Department of Obstetrics and Gynecology from 2005-2016. A Stanford faculty member since 2005, he is renowned for his expertise in gynecologic oncology, surgical innovation, and research in ovarian cancer, especially immunology and immunotherapy. He is the Group Chair of the Cooperative Ovarian Cancer Group for Immunotherapy (COGI), a part of the premiere international consortium the Gynecologic Cancer Intergroup (GCIG). An author and editor, he has published more than 300 peer-reviewed papers in the scientific literature, and an equal number of book chapters and monographs. His books, Berek & Hacker’s Gynecologic Oncology and Berek & Novak’s Gynecology, are leading texts in the field.
Dr. Berek earned his undergraduate degree in English literature and theatre arts and Master of Medical Sciences degree in biomedical sciences from Brown University. After earning his Doctor of Medicine degree from Johns Hopkins University School of Medicine, he completed an internship and residency at the Brigham & Women’s Hospital, Harvard Medical School. In 2012, he was presented the John C. Fremont Pathfinder Award, given in recognition of significant contributions to society made by a native Nebraskan.
Disclosures: In in the past two year, Dr. Berek served as a consultant and/or advisor for Atara Biotherapeutics and received research funding from Tesaro (Inst.).
Last updated: June 2016